PeptideStack
5.2kquestions
20kanswers
220users

Is orforglipron at 8 mg/mL stable enough for sixteen weeks of multi-withdrawal use?

Asked 5 Jan 2026Modified 3 months agoViewed 8.9k times
18

What I am working with: orforglipron · 8 mg/mL · sixteen weeks.

This is asserted often enough that I assumed it was established, and then I went looking for the source.

I have searched the primary literature and found one paper that is adjacent but not on point.

Has anyone verified this independently?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
bacteriostatic-water
bacteriostatic-water

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial;…

149 questions
shelf-life
shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

327 questions
orforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questions
shareeditfollowflag
TR
askedtobias_reint20k385 Jan 2026
Same question here after a warm delivery, so I am following this. – ines_brandt 8 months ago
Worth saying whether the vial has been opened, because that starts a different clock. – sinead_gaffney 9 months ago
add a comment

5 Answers

Accepted answer first, then by votes
36

Accepted answer

sixteen weeks is 112 days and, on a weekly schedule, 16 stopper punctures out of one vial at 8 mg/mL. Set the chemical question aside for a moment, because the puncture count is the one with a convention attached: 112 days is 4 times the twenty-eight days conventionally allowed for a preserved multi-dose preparation once it has been entered. Chemically, 8 mg/mL is high enough that adsorption to the glass is a rounding error and low enough that it is not protecting you from anything. What 16 withdrawals do add is 16 opportunities to introduce air, 16 coring events on the same stopper, and a headspace that grows with every draw — none of which show up on a certificate and all of which are avoided by splitting into aliquots at reconstitution.

More usefully, this is answerable from the chemistry rather than from anecdote, which is unusual and welcome.

A mass spectrum resolves most of this: minus eighteen is dehydration or succinimide, plus one is deamidation, plus sixteen is oxidation, and an unchanged mass with a shifted retention time is an isomer.

Adsorption onto glass and plastic is significant at low concentrations — micrograms per millilitre — and negligible at milligrams per millilitre. It is the usual explanation for an apparent loss in a dilute preparation.

Metal-catalysed oxidation of methionine is documented across peptide and protein formulations and is why chelators appear in some formulations.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Swirl, never shake. Aggregation is a handling problem more than a time problem.

edited 10 May 2026 by laminar_bench — added a caveat about sampling

shareimprove this answerflag
LB
answered · acceptedlaminar_bench69k5712 Apr 2026
I have kept vials both ways for a year and this matches what I saw. – Dr_Ravi_Selvarajah 4 months ago
Two lots stored differently, reassayed at a year — the difference was smaller than I expected. – Dr_Rosalind_Achebe 6 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
38

Answering this needs the physical state, since a dry powder is protected from most of these and a solution is protected from none.

Oxidation targets methionine, cysteine and tryptophan, adding sixteen daltons per oxygen. It is catalysed by trace metals and promoted by dissolved oxygen and by light.

Stated carefully, freeze-thaw cycling drives aggregation through concentration at the ice interface and pH shifts as buffer components crystallise out at different rates. Each cycle costs something.

Aggregation at air-liquid interfaces is established from surface-tension and particle-count studies and is the basis for anti-agitation handling guidance.

The caveat is that none of these pathways can be seen by looking at a vial, and a clear solution can be substantially degraded.

At dilute concentrations, suspect adsorption before you suspect chemistry.

shareimprove this answerflag
DL
answeredDr_Otto_Lindqvist72k5820 Mar 2026
16

The honest answer is that most reported "degradation" is adsorption and dilution error rather than chemistry.

Deamidation converts asparagine or glutamine to the corresponding acid via a succinimide intermediate, adding one dalton. It is base-catalysed, accelerates above neutral pH and is the dominant aqueous pathway for many peptides.

Hydrolysis cleaves the backbone, most readily at aspartate-proline and aspartate-glycine sequences, and is acid-catalysed. In a dry solid it barely proceeds at all.

Apparent loss in a dilute preparation is usually adsorption rather than degradation and is worth ruling out first.

A mass spectrum names the pathway. Plus one, plus sixteen, minus eighteen.

shareimprove this answerflag
DO
answeredDr_Malik_Osei19k2723 Apr 2026
Is there a reason to prefer minus eighty here, or is minus twenty genuinely enough? – tyndall_haze 8 months ago
add a comment
12

Aggregation is a physical process and is the one most often caused by handling rather than by time.

Aggregation is physical: peptides unfold at air-liquid interfaces and associate. Shaking maximises that interface, which is why swirling and shaking produce visibly different outcomes on the same vial.

Adsorption losses at low concentrations are quantified in formulation studies and are the reason carrier proteins are used in dilute preparations.

Sequence determines which pathways apply, so general statements are general.

Sequence decides which pathways are even available. Check the residues.

shareimprove this answerflag
EL
answeredesben_lykke84k1584 May 2026
7Confirming that opening a cold vial in a humid room is a genuinely bad idea. – imani_dube 4 months ago
6I would add a sentence about light, since tryptophan-containing sequences care. – orla_ferriter 2 months ago
add a comment
-3

Answer first: the degradation pathways worth knowing are hydrolysis, deamidation, oxidation, aggregation and adsorption, and each has a different trigger and a different mitigation.

Light exposure matters for tryptophan-containing sequences and for anything with a chromophore. Amber vials and a closed box are free mitigations.

Deamidation via the succinimide intermediate is well characterised, with sequence-dependent rates highest for asparagine-glycine motifs.

The caveat is that "within specification" and "unchanged" are different claims. A vial can lose a few per cent of content and still be usable for its purpose while no longer matching its certificate.

Cold, dry, dark, still. Those four words cover most of the mitigation.

shareimprove this answerflag
HP
answeredh_pergande71k15831 Mar 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.